Literature DB >> 7231502

Kawasaki syndrome: description of two outbreaks in the United States.

D M Bell, E W Brink, J L Nitzkin, C B Hall, H Wulff, I D Berkowitz, P M Feorino, R C Holman, C L Huntley, R H Meade, L J Anderson, S H Cheeseman, N J Fiumara, R F Gilfillan, D E Keim, J F Modlin.   

Abstract

Investigation of two outbreaks of Kawasaki syndrome (KS) in the United States in 1979 and in 1980 revealed no evidence of person-to-person transmission or of a common-source exposure among patients. Questionnaire data showed that KS was more likely to occur in children of middle and upper socioeconomic status than in those of lower status (P less than 0.05 and P less than 0.001 for the respective outbreaks) and that patients with KS had a higher incidence of an antecedent, primarily respiratory illness than did controls matched for age, sex, and race (83% of patients in the first outbreak vs. 30% of one control group, P less than 0.01, and vs. 36% of another control group, P less than 0.02; and 56% of patients in the second outbreak vs. 32% of their controls, P less than 0.02). However, laboratory studies did not identify an etiologic agent for either KS or for the antecedent illness that may be a risk factor for KS.

Entities:  

Mesh:

Year:  1981        PMID: 7231502     DOI: 10.1056/NEJM198106253042603

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  35 in total

Review 1.  Microorganisms resistant to free-living amoebae.

Authors:  Gilbert Greub; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 2.  Non-infectious makers of Kawasaki syndrome: tangible or elusive triggers?

Authors:  Donato Rigante; Giusyda Tarantino; Piero Valentini
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

3.  Kawasaki disease onset during concomitant infections with varicella zoster and Epstein-Barr virus.

Authors:  Sadi Turkay; Ender Odemis; Ahmet Karadag
Journal:  J Natl Med Assoc       Date:  2006-08       Impact factor: 1.798

4.  Concomitant respiratory viral infections in children with Kawasaki disease.

Authors:  Alejandro Jordan-Villegas; Michael L Chang; Octavio Ramilo; Asunción Mejías
Journal:  Pediatr Infect Dis J       Date:  2010-08       Impact factor: 2.129

5.  Recurrent Kawasaki disease.

Authors:  T A Vargo; J C Huhta; W H Moore; D A Person; M S Edwards
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

6.  Spatial and temporal clustering of Kawasaki syndrome cases.

Authors:  Annie S Kao; Arthur Getis; Stephanie Brodine; Jane C Burns
Journal:  Pediatr Infect Dis J       Date:  2008-11       Impact factor: 2.129

Review 7.  Parachlamydiaceae: potential emerging pathogens.

Authors:  Gilbert Greub; Didier Raoult
Journal:  Emerg Infect Dis       Date:  2002-06       Impact factor: 6.883

8.  Human coronavirus NL63 is not detected in the respiratory tracts of children with acute Kawasaki disease.

Authors:  Chisato Shimizu; Hiroko Shike; Susan C Baker; Francesca Garcia; Lia van der Hoek; Taco W Kuijpers; Sharon L Reed; Anne H Rowley; Stanford T Shulman; Helen K B Talbot; John V Williams; Jane C Burns
Journal:  J Infect Dis       Date:  2005-10-17       Impact factor: 5.226

9.  Legionella-like and other amoebal pathogens as agents of community-acquired pneumonia.

Authors:  T J Marrie; D Raoult; B La Scola; R J Birtles; E de Carolis
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

10.  Delayed diagnosis by physicians contributes to the development of coronary artery aneurysms in children with Kawasaki syndrome.

Authors:  Matthew S Wilder; Lawrence A Palinkas; Annie S Kao; John F Bastian; Christena L Turner; Jane C Burns
Journal:  Pediatr Infect Dis J       Date:  2007-03       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.